In trading on Monday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 1.6% on the day.  Components of that ETF showing particular strength include shares of Procept Biorobotics, up about 6.5% and shares of Ceribell, up about 4.1% on the day.

And under

Monday's ETF Movers: IHI, REMX  

In trading on Thursday, shares of Almonty Industries Inc (Symbol: ALM) entered into oversold territory, changing hands as low as $11.225 per share.  We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure mo

ALM Crosses Critical Technical Indicator

Almonty Industries Inc. filed a 6-K

Canada News Group News Commentary - Forecasters differ on how large the tungsten market is, but they agree on the direction. Market Data Forecast values the global market at $5.14 billion in 2025, estimates $5.56 billion for 2026, and projects $10.45 billion by 2034, a compound annual growth rate of 8.2% from 2026 to 2034. Active Companies from around the markets with current developments this week include: GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), Almonty Industries Inc. (

Tungsten Concentrate Prices Have Roughly Tripled Since January

DILLON, Mont., September 29, 2026--Almonty Industries Inc. ("Almonty" or the "Company") (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten, today issued a letter to shareholders from Lewis Black, Chairman and Chief Executive Officer of Almonty.

Almonty Issues Shareholder Letter and Provides Corporate Update

Almonty Industries Inc. engages in mining, processing, and shipping of tungsten concentrates. The company explores for tin and tungsten deposits. It holds 100% interests in the Canada, Korea, Portugal, Spain, and the United States projects and mines. The company is headquartered in Dillon, Montana.

Almonty Industries Inc. News